Alice Blue Home
URL copied to clipboard

Trending News

Healthcare stock hits 5% upper circuit after it inaugurates AI-powered Ultrasound System

Healthcare provider has introduced an AI-powered, voice-controlled ultrasound system at its Kolkata clinic. The advanced technology improves diagnostic accuracy, efficiency, and patient care, aligning with the company’s mission to revolutionize healthcare.
Healthcare stock hits 5% upper circuit after launching advanced AI-powered Ultrasound System innovation.
Healthcare stock hits 5% upper circuit after launching advanced AI-powered Ultrasound System innovation.

Introduction:

Leading healthcare provider has launched an AI-powered, voice-controlled ultrasound system at its Salt Lake clinic in Kolkata. The advanced technology enhances diagnostic accuracy, streamlines procedures, and aims to revolutionize healthcare delivery with faster, more efficient services.

Alice Blue Image

Also Read: Stocks to Consider for This New Year 2025

Share price movement of Nephro Care India:

On January 2, 2025, Nephro Care India Limited opened at ₹193.10, up 0.33% from its previous close of ₹192.50. The stock reached a high of ₹202.10 (4.99%) and a low of ₹191.50. By 3:00 PM, it traded at ₹202.10, a 4.99% increase, with a market cap of ₹333.19 crore.

Nephro Care India Launches AI Ultrasound:

Nephro Care India Limited (NCIL) has inaugurated a state-of-the-art voice-controlled, AI-powered ultrasound system, Logiq Totus, at its Salt Lake clinic in Kolkata. The advanced system will enhance diagnostic accuracy, provide real-time scan guidance, and improve operator efficiency.

The AI-enabled ultrasound machine leverages cutting-edge technology, including 2D Shear Wave Elastography and XDclear transducers, to produce high-resolution images and support multiple clinical specialties. This innovation aims to optimize diagnostic procedures and streamline healthcare delivery.

NCIL’s move aligns with its mission to revolutionize healthcare by adopting advanced technologies, including AI-driven solutions for enhanced care, reduced turnaround times, and improved patient outcomes.

Recent news on Nephro Care India:

As of December 16, 2024, Nephro Care India announced plans to expand its network by 300 clinics across India. The company emphasized the importance of a healthy lifestyle in preventing kidney diseases, which affect millions of Indians annually.

Stock performance of Nephro Care India for Period of 1 week, 1 month, and 6 months:

Nephro Care India Limited has shown a 1.32% gain over the past week, while its one-month return stands at -16.3%. Over six months, the company has posted a positive return of 7.21%, indicating a mixed short-term performance.

Also Read: Solar stock jumps 5% after it receives order worth ₹36 Cr from Tripura Renewable Energy Development Agency

Shareholding pattern of Nephro Care India:

All values in %Sep 2024Jul  2024
Promoter61.40%61.40%
FII3.90%3.00%
DII4.80%9.40%
Public29.90%26.30%
Alice Blue Image

About Nephro Care India:

Nephro Care India Limited (NSE: NEPHROCARE) is dedicated to enhancing patient care through innovative programs like Mukti, Home Dialysis, and Home Care. Their clinics offer comprehensive healthcare solutions with a focus on rehabilitation and holistic well-being.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.

Loading
Read More News

उच्चतम रिटर्न वाले स्टॉक्स: RNFI Services और 9 अन्य स्टॉक्स ने इस हफ्ते 54.65% तक का रिटर्न दिया।

पिछले हफ्ते भारत के उच्च रिटर्न देने वाले स्टॉक्स की खोज करें, उनके विकास की संभावनाओं और जोखिमों का विश्लेषण